Dendrimers as potential therapeutic tools in HIV inhibition. (Q38123954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3 references

1 June 2020

29 October 2020

25 October 2022

Dendrimers as potential therapeutic tools in HIV inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

human immunodeficiency virus infectious disease

5 March 2020

main subject

3 references

1 June 2020

1 July 2020

29 October 2020

RNA virus infectious disease

1 reference

1 July 2020

1 reference

29 October 2020

Jianqing Peng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zhenghong Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Xiaole Qi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yi Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Xiangbo Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

5 July 2013

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 June 2020

1 July 2020

29 October 2020

25 October 2022

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 June 2020

1 July 2020

29 October 2020

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

7912-7929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

5 March 2020

copyright license

4 references

1 June 2020

1 July 2020

29 October 2020

25 October 2022

0 references

Dendrimers in biomedical applications--reflections on the field

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Dendrimer-drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Structure activity relationship of dendrimer microbicides with dual action antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Synthesis of a new amphiphilic glycodendrimer with antiviral functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

The cluster glycoside effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Synthesis of sulfated alkyl malto- and laminara-oligosaccharides with potent inhibitory effects on AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Quantitative study of HIV-1 Tat peptide and TAR RNA interaction inhibited by poly(allylamine hydrochloride).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

"Viologen" dendrimers as antiviral agents: the effect of charge number and distance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

HIV protease-mediated activation of sterically capped proteasome inhibitors and substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Dendritic cell-based human immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

In vitro studies of water-stable cationic carbosilane dendrimers as delivery vehicles for gene therapy against HIV and hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Carbosilane dendrimers to transfect human astrocytes with small interfering RNA targeting human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Complexation of HIV derived peptides with carbosilane dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18077912

Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion

21 January 2018

1 reference

12 December 2020

Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle

1 reference

12 December 2020

Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells

1 reference

12 December 2020

SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques

1 reference

12 December 2020

Antisense approaches in drug discovery and development.

1 reference

12 December 2020

Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer

1 reference

12 December 2020

VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection

1 reference

12 December 2020

Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes

1 reference

12 December 2020

Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features.

1 reference

12 December 2020

Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line

1 reference

12 December 2020

Antiviral therapy for human immunodeficiency virus infections

1 reference

12 December 2020

10.3390/MOLECULES18077912

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

23884127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884127%20AND%20SRC:MED&resulttype=core&format=json